FDA Authorizes Johnson & Johnson Covid-19 Vaccine for Emergency Use
On Saturday, the FDA authorized the Johnson & Johnson Covid-19 vaccine for emergency use authorization.
Said White House Senior for Covid-19 Response, Andy Slavitt, "A third safe and effective vaccine is very welcome news."
Johnson & Johnson says they can begin delivering the vaccine next week. The vaccine is the first single-dose vaccine authorized to treat the virus.
The J&J vaccine was found to be 66.9% effective at preventing moderate to severe Covid-19 symptoms and 85% effective against very serious symptoms.
J&J says they can roll-out 100 million doses by the end of June.
Although less effective than the two-dose Pfizer and Moderna vaccines, J&J's single-dose vaccine could be much easier to roll-out and does not require the same sub-zero refrigeration, facilitating transportation and storage.
Photo Source: Angelo Esslinger